Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

ClinicalTrials.gov ID: NCT00615251

Public ClinicalTrials.gov record NCT00615251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Single-Blind, Randomized Study to Compare DR-2011 to a Progesterone Gel for Luteal Phase Supplementation for In Vitro Fertilization

Study identification

NCT ID
NCT00615251
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
1,297 participants

Conditions and interventions

Conditions

Interventions

  • DR-2011 Drug
  • Crinone 8% Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 42 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jul 31, 2009
Completion
Jul 31, 2009
Last update posted
Sep 12, 2013

2008 – 2009

United States locations

U.S. sites
29
U.S. states
14
U.S. cities
29
Facility City State ZIP Site status
Duramed Investigational Site Tarzana California 91356
Duramed Investigational Site West Los Angeles California 90064
Duramed Investigational Site Westlake California 91361
Duramed Investigational Site Clearwater Florida 33759
Duramed Investigational Site Alpharetta Georgia 30005
Duramed Investigational Site Atlanta Georgia 30342
Duramed Investigational Site Boise Idaho 83702
Duramed Investigational Site Chicago Illinois 60610
Duramed Investigational Site Highland Park Illinois 60035
Duramed Investigational Site Rockville Maryland 20850
Duramed Investigational Site Dearborn Michigan 48126
Duramed Investigational Site Flint Michigan 48503
Duramed Investigational Site Rochester Hills Michigan 48307
Duramed Investigational Site Saginaw Michigan 48604
Duramed Investigational Site Ypsilanti Michigan 48197
Duramed Investigational Site Woodbury Minnesota 55125
Duramed Investigational Site Reno Nevada 89511
Duramed Investigational Site Marlton New Jersey 08053
Duramed Investigational Site Morristown New Jersey 07960
Duramed Investigational Site Cincinnati Ohio 45209
Duramed Investigational Site Sylvania Ohio 43560
Duramed Investigational Site Columbia South Carolina 29201
Duramed Investigational Site Mt. Pleasant South Carolina 29464
Duramed Investigational Site Myrtle Beach South Carolina 29577
Duramed Investigational Site Austin Texas 78731
Duramed Investigational Site Beaumont Texas 77706
Duramed Investigational Site Bedford Texas 76022
Duramed Investigational Site Webster Texas 77598
Duramed Investigational Site Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00615251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 12, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00615251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →